However, IFN-γ and their receptor expression in CD8+ T cells may also be influenced by epigenetic modifications [47] and, therefore, functional investigations are necessitated to confirm impaired IFN-γ release by CD8+ TILs in CRC patients. This evidence concerns the gene CD8A and colorectal carcinoma.